Savill Corrine - Insider Non-Derivative Transactions at Cullinan Therapeutics, Inc. (CGEM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 22, 2024, Savill Corrine's relationship to Cullinan Therapeutics, Inc. (CGEM) is Officer (Chief Business Officer), and currently has 203,490 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CGEM insiders.
Data Source: SEC.
Savill Corrine - Insider Non-Derivative Transactions of CGEM Common Stock
Savill Corrine - Insider Non-Derivative Transactions at CGEM
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 23, 2024 | Acquisition -- (Common Stock) | 37500 | 0 | 203490 |
| Feb 2, 2024 | Sell -- (Common Stock) | 40000 | 16.18 | 165990 |
| Feb 2, 2024 | M -- (Common Stock) | 40000 | 4.3 | 205990 |
| Jan 30, 2024 | Sell -- (Common Stock) | 40000 | 14.09 | 165990 |
| Jan 30, 2024 | M -- (Common Stock) | 40000 | 4.3 | 205990 |
| Jan 24, 2024 | Sell -- (Common Stock) | 21316 | 12.46 | 165990 |
| Jan 24, 2024 | M -- (Common Stock) | 21316 | 4.3 | 187306 |
| Jan 23, 2024 | Sell -- (Common Stock) | 4125 | 12.02 | 165990 |
| Jan 23, 2024 | Sell -- (Common Stock) | 14559 | 12.18 | 170115 |
| Jan 23, 2024 | M -- (Common Stock) | 14559 | 4.3 | 184674 |
| Feb 18, 2023 | Acquisition -- (Common Stock) | 20500 | 0 | 170115 |